Bellevue Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20
Closed -$1.02K 510
2024
Q4
$1.02K Buy
+20
New +$983 ﹤0.01% 489
2024
Q1
Sell
-20
Closed -$1.3K 465
2023
Q4
$1.3K Hold
20
﹤0.01% 437
2023
Q3
$1.31K Hold
20
﹤0.01% 429
2023
Q2
$1.16K Hold
20
﹤0.01% 467
2023
Q1
$1.23K Hold
20
﹤0.01% 475
2022
Q4
$1.25K Hold
20
﹤0.01% 463
2022
Q3
$1K Hold
20
﹤0.01% 491
2022
Q2
$1K Hold
20
﹤0.01% 493
2022
Q1
$2K Sell
20
-1
-5% -$82 ﹤0.01% 491
2021
Q4
$2K Sell
21
-2
-9% -$171 ﹤0.01% 525
2021
Q3
$2K Hold
23
﹤0.01% 549
2021
Q2
$2K Sell
23
-2
-8% -$194 ﹤0.01% 549
2021
Q1
$3K Sell
25
-3
-11% -$311 ﹤0.01% 543
2020
Q4
$3K Buy
+28
New +$1.98K ﹤0.01% 557

Other funds holding NARI

Bellevue Asset Management's NARI Position: Q1 2025 in Review

Bellevue Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 20 shares — an estimated $1.02K sold.

Bellevue Asset Management first reported a position in NARI in Q4 2020 and held it in 14 quarters. The position peaked at $3K in Q1 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Bellevue Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bellevue Asset Management sold 20 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $1.02K.
  • Bellevue Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Bellevue Asset Management's Inari Medical, Inc. Common Stock position peaked at $3K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Bellevue Asset Management's 13F filing for Q1 2025, filed 28 Apr 2025.